LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Recurrent Mutation Linked to Childhood Blindness

By LabMedica International staff writers
Posted on 29 May 2017
Print article
Image: Scientists have identified a genetic mutation that contributes to sight loss in children (Photo courtesy of the University of Edinburgh).
Image: Scientists have identified a genetic mutation that contributes to sight loss in children (Photo courtesy of the University of Edinburgh).
Researchers have identified a genetic mutation that contributes to the sight loss that occurs in children with ocular coloboma, a developmental defect that causes part of the eye to be missing at birth. The findings shed light on its causes and help explain how genes contribute to development of the eye.

Ocular coloboma is a developmental defect in optic fissure closure and is a common cause of severe congenital visual impairment. Coloboma can have profound, devastating effects on visual ability, accounting for up to 10% of all childhood blindness. It can cause a distinctive keyhole-shaped pupil as it commonly results in a missing segment in the iris. However, coloboma is very variable and therefore likely to be caused by a number of genes. Few genetic causes have so far been found to help explain the cause of coloboma.

The research team, led by Dr. Joe Rainger University of Edinburgh, worked with 12 families, studying the DNA of children with coloboma and their unaffected parents. Using state-of-the-art genetic screening by whole exome sequencing, the scientists revealed mutations in 10 genes, 3 of which were linked to activity of one molecule: actin, important for various vital cell functions, including in defining cell shape and structure via maintenance of the cytoskeleton.

Targeted gene sequencing was then carried out on a further 380 people with coloboma. This showed that one of the mutations – a specific alteration in the gene ACTG1 – recurred across a number of those tested. The scientists edited this ACTG1 mutation into a line of mice using cutting-edge CRISPR/Cas9 gene-editing technology, and found that it had severe effects on actin function.

The newly identified mutations are thought to affect how actin binds to other proteins and on actin stability, which could severely affect development of the eye in the womb. The findings add knowledge to our understanding of coloboma onset as well as on the importance of actin to eye development.

The study, by Rainger J et al, was published May 11, 2017, in the journal Human Mutation.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more